Search results - ORA - Oxford University Research Archive

« Previous | 1 - 10 of 24 | Next »

1

Journal article

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin - Systematic overview of individual data from 96,712 randomized patients

Latini, R, Tognoni, G, Maggioni, AP, et al.
2000-06-05

2

Journal article

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

Preiss, D, Giles, TD, Thomas, LE, et al.
2013-09-05

3

Journal article

Indications for ACE inhibitors in the early treatment of acute myocardial infarction - Systematic overview of individual data from 100,000 patients in randomized trials

Franzosi, MG, Santoro, E, Zuanetti, G, et al.
1998-06-09

4

Journal article

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

Preiss, D, Campbell, RT, Murray, HM, et al.
2015-06-05

5

Journal article

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.

Latini, R, Tognoni, G, Maggioni, AP, et al.
2000-06-05

6

Journal article

Quality of care of children with chronic diseases in Alexandria, Egypt: the models of asthma, type I diabetes, epilepsy, and rheumatic heart disease. Egyptian-Italian Collaborative Group on Pediatric Chronic Diseases.

Bassili, A, Zaki, A, Zaher, SR, et al.
2000-07-05

7

Journal article

Effect of valsartan on the incidence of diabetes and cardiovascular events.

McMurray, JJ, Holman, RR, Haffner, SM, et al.
2010-04-05

8

Journal article

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.

Latini, R, Tognoni, G, Maggioni, AP, et al.
2000-06-05

9

Journal article

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

Latini, R, Staszewsky, L, Sun, JL, et al.
2013-11-05

10

Journal article

Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

Mcmurray, JJV, Laakso, M, Standl, E, et al.
2011-08-05

TO TOP